These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Induction of murine lymphokine-activated killer cells by recombinant IL-7. Lynch DH; Miller RE J Immunol; 1990 Sep; 145(6):1983-90. PubMed ID: 1975262 [TBL] [Abstract][Full Text] [Related]
23. Regulation of lymphokine-activated killer activity in T-replete and T-cell-depleted human bone marrow by interleukin 4. Drobyski WR; LeFever AV; Truitt RL Exp Hematol; 1991 Oct; 19(9):950-7. PubMed ID: 1716592 [TBL] [Abstract][Full Text] [Related]
24. The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum. Webb BJ; Bochan MR; Montel A; Padilla LM; Brahmi Z Cell Immunol; 1994 Dec; 159(2):246-61. PubMed ID: 7994757 [TBL] [Abstract][Full Text] [Related]
25. In vivo and ex vivo antitumor activity in patients receiving low-dose subcutaneous recombinant interleukin-2. Schomburg A; Menzel T; Körfer A; Heer G; Dallmann I; Kirchner H; Poliwoda H; Atzpodien J Nat Immun; 1992; 11(3):133-43. PubMed ID: 1392401 [TBL] [Abstract][Full Text] [Related]
27. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation. Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491 [TBL] [Abstract][Full Text] [Related]
28. Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes. Inhibition by transforming growth factor-beta. Smyth MJ; Strobl SL; Young HA; Ortaldo JR; Ochoa AC J Immunol; 1991 May; 146(10):3289-97. PubMed ID: 1827481 [TBL] [Abstract][Full Text] [Related]
29. Enhancement of murine lymphokine-activated killer cell activity by retinoic acid. Lin TH; Chu TM Cancer Res; 1990 May; 50(10):3013-8. PubMed ID: 1970751 [TBL] [Abstract][Full Text] [Related]
30. Regulation of lymphokine-activated killer cell induction by human recombinant IL-1 receptor antagonist. Obligate paracrine pathway of IL-1 during lymphokine-activated killer cell induction. Fujiwara T; Grimm EA J Immunol; 1992 May; 148(9):2941-6. PubMed ID: 1374105 [TBL] [Abstract][Full Text] [Related]
31. Augmentation of lymphokine-activated killer cell activity by lentinan. Tani M; Tanimura H; Yamaue H; Tsunoda T; Iwahashi M; Noguchi K; Tamai M; Hotta T; Mizobata S Anticancer Res; 1993; 13(5C):1773-6. PubMed ID: 8267381 [TBL] [Abstract][Full Text] [Related]
32. Influence of various cytokines on the induction of lymphokine-activated killer cells. Bergmann L; Weidmann E; Bungert B; Hechler P; Mitrou PS Nat Immun Cell Growth Regul; 1990; 9(4):265-73. PubMed ID: 2120581 [TBL] [Abstract][Full Text] [Related]
33. Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes: modulation of recognition through retroviral transduction of tumor cells with interleukin 2 complementary DNA and exogenous alpha interferon treatment. Schendel DJ; Gansbacher B Cancer Res; 1993 Sep; 53(17):4020-5. PubMed ID: 8358731 [TBL] [Abstract][Full Text] [Related]
34. Interleukin 2 protects hairy leukemic cells from lymphokine-activated killer cell-mediated cytotoxicity. Reiter Z; Taylor MW Cancer Res; 1993 Aug; 53(15):3555-60. PubMed ID: 7687924 [TBL] [Abstract][Full Text] [Related]
35. Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells. Brandau S; Suttmann H; Riemensberger J; Seitzer U; Arnold J; Durek C; Jocham D; Flad HD; Böhle A Clin Cancer Res; 2000 Sep; 6(9):3729-38. PubMed ID: 10999767 [TBL] [Abstract][Full Text] [Related]
38. Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas. Itoh K; Tilden AB; Balch CM Cancer Res; 1986 Jun; 46(6):3011-7. PubMed ID: 3486040 [TBL] [Abstract][Full Text] [Related]
39. In vivo induction of lymphokine-activated killer cells by interleukin-2 splenic artery perfusion in advanced malignancy. Klasa RJ; Silver HK; Kong S Cancer Res; 1990 Aug; 50(16):4906-10. PubMed ID: 2379154 [TBL] [Abstract][Full Text] [Related]
40. Generation of lymphokine-activated killer activity in T cells. Possible regulatory circuits. Geller RL; Smyth MJ; Strobl SL; Bach FH; Ruscetti FW; Longo DL; Ochoa AC J Immunol; 1991 May; 146(10):3280-8. PubMed ID: 1673980 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]